| Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression CH Chan, JK Morrow, CF Li, Y Gao, G Jin, A Moten, LJ Stagg, JE Ladbury, ... Cell 154 (3), 556-568, 2013 | 415 | 2013 |
| The nano-plasma interface: Implications of the protein corona J Wolfram, Y Yang, J Shen, A Moten, C Chen, H Shen, M Ferrari, Y Zhao Colloids and Surfaces B: Biointerfaces 124, 17-24, 2014 | 233 | 2014 |
| The Skp2 pathway: a critical target for cancer therapy Z Cai, A Moten, D Peng, CC Hsu, BS Pan, R Manne, H Li, HK Lin Seminars in cancer biology 67, 16-33, 2020 | 131 | 2020 |
| Redefining global health priorities: Improving cancer care in developing settings A Moten, D Schafer, M Ferrari Journal of global health 4 (1), 2014 | 92 | 2014 |
| Akt: a new activation mechanism Y Gao, A Moten, HK Lin Cell research 24 (7), 785-786, 2014 | 90 | 2014 |
| Cycles of ubiquitination and deubiquitination critically regulate growth factor–mediated activation of Akt signaling WL Yang, G Jin, CF Li, YS Jeong, A Moten, D Xu, Z Feng, W Chen, Z Cai, ... Science signaling 6 (257), ra3-ra3, 2013 | 77 | 2013 |
| The role of Skp2 in hematopoietic stem cell quiescence, pool size, and self-renewal J Wang, F Han, J Wu, SW Lee, CH Chan, CY Wu, WL Yang, Y Gao, ... Blood, The Journal of the American Society of Hematology 118 (20), 5429-5438, 2011 | 65 | 2011 |
| Novel ARF/p53-independent senescence pathways in cancer repression CH Chan, Y Gao, A Moten, HK Lin Journal of molecular medicine 89, 857-867, 2011 | 31 | 2011 |
| A prescription for health inequity: building public health infrastructure in resource-poor settings A Moten, DF Schafer, E Montgomery Journal of Global Health 2 (2), 2012 | 14 | 2012 |
| The foundational framework of tumors: Gametogenesis, p53, and cancer C Liu, A Moten, Z Ma, HK Lin Seminars in cancer biology 81, 193-205, 2022 | 12 | 2022 |
| Global health engagement and the Department of Defense as a vehicle for security and sustainable global health A Moten, D Schafer, EK Burkett Military medicine 183 (1-2), 14-17, 2018 | 9 | 2018 |
| A paradigm shift in critical care infrastructure in complex settings: evaluating an Ultraportable operating room to improve field surgical safety DL Teodorescu, S Okajima, A Moten, MHM Teodorescu, M El Hechi, ... Military Medicine 186 (Supplement_1), 295-299, 2021 | 6 | 2021 |
| User-centred innovation to advance safe surgery at the point of need: report on development of the SurgiField system DL Teodorescu, S Jonnalagedda, A Rakin, MHM Teodorescu, M Kenney, ... BMJ Innovations 8 (4), 2022 | 3 | 2022 |
| A Health Disparity Action Plan: Achieving Equity through Clinical Trials, Affordable Care, and Professional Development Schafer, Moten, Lushniak, Ferrari, Khan, Burkett, Schafer Journal of Health Disparities Research and Practice 12 (6), 2019 | 3 | 2019 |
| A paradigm shift in public health structures: creating sustainable systems to achieve global healthcare equity D Schafer, A Moten Antimicrobial Resistance and Infection Control 4 (Suppl 1), P105, 2015 | 2 | 2015 |
| Randomised controlled trials as a driving force of evidence-based public health on the population level A Moten, D Schafer, EH Fletcher, E Montgomery Perspectives in public health 136 (1), 25-27, 2016 | 1 | 2016 |
| CRITICAL MANAGEMENT OF A RARE LIFE-THREATENING ENDOVASCULAR COMPLICATION OF SALMONELLA ENTERICA BACTEREMIA A Moten, J Gray, A Barelski Chest 156 (4), A75, 2019 | | 2019 |
| A targeted multi-stage nano-therapeutic to modulate immunotherapy A Moten Translational Medicine, 2015 | | 2015 |
| Celastrol-loaded liposomes as nano-drugs for the potential treatment of prostate cancer J Wolfram, C Celia, C Borsoi, A Moten, D Paolino, M Fresta, H Shen, ... | | 2014 |
| The role of Skp2 in hematopoietic stem cell quiescence, pool size and HK Lin, X Zhang, YS Jeong, A Moten, F Samaniego, P Huang, Q Liu, ... | | 2011 |